Showing results (71-80 of 220) with videos related to
Sort By:
Pageof 22
Pathology, Research and Practice|January 26, 2024
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysisMatteo Rosellini, Veronica Mollica, Andrea Marchetti, et al.Oncology Reports|August 19, 2011
Sunitinib inhibits tumor vascularity and growth but does not affect Akt and ERK phosphorylation in xenograft tumorsPasquale Voce, Maria D'Agostino, Sonia Moretti, et al.Plos One|February 8, 2014
Next generation sequencing improves the accuracy of KRAS mutation analysis in endoscopic ultrasound fine needle aspiration pancreatic lesionsDario de Biase, Michela Visani, Paola Baccarini, et al.Thyroid : Official Journal of the American Thyroid Association|August 19, 2007
Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implicationsRonald A Ghossein, Rebecca Leboeuf, Kepal N Patel, et al.Journal of Neuro-Oncology|July 28, 2017
Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteriaMichela Visani, Giorgia Acquaviva, Gianluca Marucci, et al.Oncotargets and Therapy|August 17, 2013
454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samplesAnnalisa Altimari, Dario de Biase, Giovanna De Maglio, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 10, 2014
Anoctamin 1 is apically expressed on thyroid follicular cells and contributes to ATP- and calcium-activated iodide effluxCarmela Iosco, Cristina Cosentino, Laura Sirna, et al.Journal of Clinical Pathology|January 23, 2015
KRAS mutant allele-specific imbalance (MASI) assessment in routine samples of patients with metastatic colorectal cancerUmberto Malapelle, Roberta Sgariglia, Alfonso De Stefano, et al.The Journal of Clinical Endocrinology and Metabolism|May 1, 2014
High-sensitivity BRAF mutation analysis: BRAF V600E is acquired early during tumor development but is heterogeneously distributed in a subset of papillary thyroid carcinomasDario de Biase, Valentina Cesari, Michela Visani, et al.Virchows Archiv : an International Journal of Pathology|July 20, 2020
Coexisting well-differentiated and anaplastic thyroid carcinoma in the same primary resection specimen: immunophenotypic and genetic comparison of the two components in a consecutive series of 13 cases and a review of the literatureMoira Ragazzi, Federica Torricelli, Benedetta Donati, et al.Pageof 22